1. Home
  2. EXAS vs ENTG Comparison

EXAS vs ENTG Comparison

Compare EXAS & ENTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.89

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Logo Entegris Inc.

ENTG

Entegris Inc.

HOLD

Current Price

$116.43

Market Cap

17.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
ENTG
Founded
1995
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
17.0B
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
EXAS
ENTG
Price
$103.89
$116.43
Analyst Decision
Hold
Buy
Analyst Count
17
11
Target Price
$86.62
$127.80
AVG Volume (30 Days)
1.8M
2.0M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
0.35%
EPS Growth
80.32
N/A
EPS
N/A
1.55
Revenue
$4,144,000.00
$3,196,600,000.00
Revenue This Year
$15.37
$9.27
Revenue Next Year
$12.41
$9.39
P/E Ratio
N/A
$74.87
Revenue Growth
N/A
N/A
52 Week Low
$38.88
$60.75
52 Week High
$104.02
$142.50

Technical Indicators

Market Signals
Indicator
EXAS
ENTG
Relative Strength Index (RSI) 61.72 46.14
Support Level $103.10 $108.56
Resistance Level N/A $124.00
Average True Range (ATR) 0.31 5.61
MACD -0.03 -1.43
Stochastic Oscillator 86.96 31.95

Price Performance

Historical Comparison
EXAS
ENTG

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

Share on Social Networks: